Justia Lawyer Rating - Badge
NYSTLA - Badge
Avvo Rating - Badge
American Association for Justice - Badge

Allegations Against China Medical May Lead to Claims for Investors

InvestorLawyers

Investment attorneys are seeking investors who purchased China Medical Technologies Inc. securities in connection with recent fraud allegations made against the company. Officers and directors of China Medical may have violated federal securities laws and, as a result, investors in the company may have a valid securities arbitration claim. China Medical, a Chinese company listed in North America, handles the developing, manufacturing and marketing for medical devices, including molecular and immunodiagnostic products.

Allegations against China Medical may lead to Claims for Investors

China Medical shares saw a 23 percent plunge on December 6, 2011. The significant plunge in value marks an all-time low for the firm’s shares. The plunge followed Glaucus Research Group’s allegations that Xiaodong Wu, China Medical’s CEO, “orchestrated an acquisition to embezzle roughly $20-$23 million from the public company.” According to the research firm, China Medical acquired an entity at a price far over its value that the firm believes is secretly related to China Medical’s CEO.

Furthermore, Glaucus alleges that the firm’s primary business segment was sold to the chairman by China Medical. This primary business segment — which develops products that are used in the treatment of benign tumors and solid cancers — was the firm’s biggest revenue generator from the time of the firm’s inception. The reason for this transaction stems from the impending suspension of China Medical’s permit to sell HIFU products by the Chinese FDA. China Medical’s core business segment would have been rendered worthless if the company’s permit was suspended.

China Medical denies all allegations that it defrauded investors. However, if it is proven that China Medical did, in fact, violate federal securities laws, investors who incurred losses may be entitled to compensation.

Individuals who purchased China Medical Technologies Inc. securities should contact an investment attorney immediately. To find out more about your legal rights and options, contact The Law Office of Christopher J. Gray at (866) 966-9598 for a no-cost, confidential consultation.

Client Reviews

Chris did a great job with my case. He managed my expectations in the beginning of the process, consulted me along the way and always made sure I knew the advantages and disadvantages of decisions we collectively needed to make. He is very knowledgable about the finanical industry and how they work...

Greg

Chris displayed extreme professionalism. His dedication, research, and concern for his clients pocket book was displayed to the fullest when Chris tried my case. His diligence and perserverance were rewarded when we won our case. I have reccommended Chris to numerous friends who have concurred with...

Jay

Chris became my lawyer for a FINRA Arbitration case in 2008. He listened to my complaint, filed notice soon after and engaged an expert witness. We discussed mediation, found it to be agreeable and approached the defendant who at first agreed and at the last minute reneged. At all times Chris kept...

Andrew

Contact Us

  1. 1 Law Firm Accepting Cases Throughout the U.S.
  2. 2 Experienced Representation
  3. 3 Established Record of Substantial Recoveries
Fill out the contact form or call us at (866) 966-9598 to schedule your consultation.

Leave Us a Message